HER2 Support Group Forums - At 2014 San Antonio Breast Cancer Symposium three new Myriad studies highlighted

HER2 Support Group Forums (https://her2support.org/vbulletin/index.php)

- Breast Cancer Newsfeed (https://her2support.org/vbulletin/forumdisplay.php?f=52)

- - At 2014 San Antonio Breast Cancer Symposium three new Myriad studies highlighted (https://her2support.org/vbulletin/showthread.php?t=62362)

News	12-13-2014 02:18 AM

At 2014 San Antonio Breast Cancer Symposium three new Myriad studies highlighted

Myriad Genetics, Inc. (NASDAQ: MYGN) has announced results from a new study that demonstrated the ability of the myRisk™ Hereditary Cancer test to detect 105 percent more mutations in cancer...

More...

All times are GMT -7. The time now is 09:32 AM.